Zur Übersicht

14:30 - 16:00 Uhr

Fachgebiet: Allgemeinmedizin , Bildungszentrum , Fachübergreifende Veranstaltung , Infektiologie , Virologie , Zentrum für Klinische Studien (ZKS)

Fourth dose COVID-19 Vaccination - Experiences from Israel & UK

Join us for the last VACCELERATE webinar before the summer break to learn more about the experiences from Israel and the UK.

1. Fourth dose vaccination in Israel

Yair Goldberg, Technion - Israel Institute of Technology, Haifa, Israel and

Amit Huppert, The Gertner Institute for Epidemiology & Health Policy Research, Sheba Medical Center, Israel

In January 2022, Israel began administering a fourth dose of BNT162b2 vaccine to persons 60 years or older. Using the Israeli Ministry of Health database, the team around Goldberg and Huppert extracted data on 1,2 million persons who were 60 years or older and eligible for the fourth dose during a period in which the B.1.1.529 (omicron) variant of SARS-CoV-2 was predominant (January to March 2022).

2. Fourth dose vaccination in UK (COV-BOOST)

Saul N. Faust, NIHR Southampton Clinical Research Facility and Biomedical Research Centre, Southampton, UK

The COV-BOOST trial aimed to investigate the safety, reactogenicity, and immunogenicity of booster doses against COVID-19.

  • Thema:

    Fourth dose COVID-19 Vaccination - Experiences from Israel & UK

  • Datum:

    Montag, 27. Juni 2022 , um 14:30 - 16:00 Uhr

Zur Übersicht

Nach oben scrollen